Your browser doesn't support javascript.
loading
Design and Synthesis of a Screening Library Using the Natural Product Scaffold 3-Chloro-4-hydroxyphenylacetic Acid.
Kumar, Rohitesh; Sadowski, Martin C; Levrier, Claire; Nelson, Colleen C; Jones, Amy J; Holleran, John P; Avery, Vicky M; Healy, Peter C; Davis, Rohan A.
Affiliation
  • Kumar R; †Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia.
  • Sadowski MC; ‡Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4102, Australia.
  • Levrier C; †Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia.
  • Nelson CC; ‡Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4102, Australia.
  • Jones AJ; ‡Australian Prostate Cancer Research Centre-Queensland, Institute of Health and Biomedical Innovation, Queensland University of Technology, Princess Alexandra Hospital, Translational Research Institute, Brisbane, QLD 4102, Australia.
  • Holleran JP; †Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia.
  • Avery VM; †Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia.
  • Healy PC; †Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia.
  • Davis RA; †Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia.
J Nat Prod ; 78(4): 914-8, 2015 Apr 24.
Article de En | MEDLINE | ID: mdl-25803573
ABSTRACT
The fungal metabolite 3-chloro-4-hydroxyphenylacetic acid (1) was utilized in the generation of a unique drug-like screening library using parallel solution-phase synthesis. A 20-membered amide library (3-22) was generated by first converting 1 to methyl (3-chloro-4-hydroxyphenyl)acetate (2), then reacting this scaffold with a diverse series of primary amines via a solvent-free aminolysis procedure. The structures of the synthetic analogues (3-22) were elucidated by spectroscopic data analysis. The structures of compounds 8, 12, and 22 were confirmed by single X-ray crystallographic analysis. All compounds were evaluated for cytotoxicity against a human prostate cancer cell line (LNCaP) and for antiparasitic activity toward Trypanosoma brucei brucei and Plasmodium falciparum and showed no significant activity at 10 µM. The library was also tested for effects on the lipid content of LNCaP and PC-3 prostate cancer cells, and it was demonstrated that the fluorobenzyl analogues (12-14) significantly reduced cellular phospholipid and neutral lipid levels.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Phénylacétates / Produits biologiques Type d'étude: Diagnostic_studies / Screening_studies Limites: Humans / Male Langue: En Journal: J Nat Prod Année: 2015 Type de document: Article Pays d'affiliation: Australie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Phénylacétates / Produits biologiques Type d'étude: Diagnostic_studies / Screening_studies Limites: Humans / Male Langue: En Journal: J Nat Prod Année: 2015 Type de document: Article Pays d'affiliation: Australie